Pediatric multisystem inflammatory syndrome temporally associated with SARS-COV-2: Oral manifestations and implications
Language English Country Great Britain, England Media print-electronic
Document type Letter
PubMed
32767455
PubMed Central
PMC7436594
DOI
10.1111/ipd.12694
Knihovny.cz E-resources
- MeSH
- COVID-19 * MeSH
- Child MeSH
- Humans MeSH
- SARS-CoV-2 * MeSH
- Systemic Inflammatory Response Syndrome MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Letter MeSH
Department of Prosthodontics Faculty of Dentistry Istanbul Medipol University Istanbul Turkey
Department of Public Health Faculty of Medicine Masaryk University Brno Czech Republic
See more in PubMed
Mallineni SK, Innes NP, Raggio DP, Araujo MP, Robertson MD, Jayaraman J. Coronavirus disease (COVID‐19): characteristics in children and considerations for dentists providing their care. Int J Paediatr Dent. 2020;30(3):245‐250. PubMed PMC
Viner RM, Whittaker E. Kawasaki‐like disease: emerging complication during the COVID‐19 pandemic. Lancet. 2020;395(10239):1741‐1743. PubMed PMC
Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki‐like disease at the Italian epicentre of the SARS‐CoV‐2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771‐1778. PubMed PMC
Pouletty M, Borocco C, Ouldali N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS‐CoV‐2 mimicking Kawasaki disease (Kawa‐COVID‐19): a multicentre cohort. Ann Rheum Dis. 2020;79(8):999‐1006. PubMed PMC
Cheung EW, Zachariah P, Gorelik M, et al. Multisystem inflammatory syndrome related to COVID‐19 in previously healthy children and adolescents in New York City. JAMA. 2020;324(3):294. PubMed PMC
Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS‐CoV‐2. JAMA. 2020;324(3):259–269. PubMed PMC
Kaur G, Gupta J, Verma L, Passi S, Joshi M. Recurrent Kawasaki Disease presenting to dentists: “Think Beyond Dentition”. Int J Clin Pediatr Dent. 2018;11(6):535. PubMed PMC
Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr. 1994;83(10):1057‐1060. PubMed
Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87(5):1776‐1780. PubMed
Deza Leon MP, Redzepi A, McGrath E, et al. COVID‐19–associated pediatric multisystem inflammatory syndrome. J Pediatric Infect Dis Soc. 2020;9(3):407‐408. PubMed PMC
Çakan M, Aktay Ayaz N, Keskindemirci G, Onan SH, Aköz SF. A case of Kawasaki disease with severe Lip and oral mucosa involvement complicated with microstomia and corrected with surgery. Arch Rheumatol. 2018;33(2):238‐240. PubMed PMC
Scardina GA, Fucà G, Carini F, et al. Oral necrotizing microvasculitis in a patient affected by Kawasaki disease. Med Oral Patol Oral Cir Bucal. 2007;12(8):560‐564. http://www.medicinaoral.com/pubmed/medoralv12_i8_pE560.pdf. Accessed June 18, 2020. PubMed
Maheshwari AK, Mandowara P. Oral lesions in Kawasaki disease. IOSR J Dent Med Sci. 2018;17:6‐9.
World Health Organization (WHO) . Multisystem inflammatory syndrome in children and adolescents temporally related to COVID‐19. https://www.who.int/news‐room/commentaries/detail/multisystem‐inflammatory‐syndrome‐in‐children‐and‐adolescents‐with‐covid‐19. Published May 17, 2020. Accessed June 18, 2020.
Centers for Disease Control and Prevention (CDC) . Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with Coronavirus Disease. 2019.
Angular cheilitis of COVID-19 patients: A case-series and literature review
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
The manifestation of oral mucositis in COVID-19 patients: A case-series